|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0039725,
umls-concept:C0087111,
umls-concept:C0205284,
umls-concept:C0392747,
umls-concept:C0439234,
umls-concept:C0443172,
umls-concept:C0549178,
umls-concept:C0871261,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C1709274,
umls-concept:C2825812,
umls-concept:C2911692
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2009-2-23
|
|
pubmed:abstractText |
Artemisinin combination treatments (ACT) are recommended as first line treatment for falciparum malaria throughout the malaria affected world. We reviewed the efficacy of a 3-day regimen of mefloquine and artesunate regimen (MAS(3)), over a 13 year period of continuous deployment as first-line treatment in camps for displaced persons and in clinics for migrant population along the Thai-Myanmar border.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/19234601-10365399,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19234601-11071185,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19234601-11127318,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19234601-11132385,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19234601-11132386,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19234601-12377597,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19234601-12471569,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19234601-12958120,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19234601-1364859,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19234601-15115123,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19234601-15288742,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19234601-15499533,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19234601-15504852,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19234601-15689066,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19234601-15691128,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19234601-15721465,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19234601-15878153,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19234601-16028147,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19234601-16179089,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19234601-16451346,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19234601-17054744,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19234601-18420924,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19234601-18471066,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19234601-7930743,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19234601-8036679,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19234601-8761562,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19234601-9210658,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19234601-9449273,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19234601-9463672,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19234601-9561593,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19234601-9988316
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1932-6203
|
|
pubmed:author |
pubmed-author:AndersonTimT,
pubmed-author:AshleyElizabeth AEA,
pubmed-author:BarendsMarionM,
pubmed-author:BrockmanAlanA,
pubmed-author:CarraraVerena IlonaVI,
pubmed-author:HutagalungRobertR,
pubmed-author:ImwongMallikaM,
pubmed-author:LwinKhin MaungKM,
pubmed-author:McGreadyRoseR,
pubmed-author:NostenFrançoisF,
pubmed-author:PhaiphunLucyL,
pubmed-author:PhyoAung PyaeAP,
pubmed-author:PreechapornkulPiyanuchP,
pubmed-author:ProuxStephaneS,
pubmed-author:PukrittayakameeSasithonS,
pubmed-author:SinghasivanonPratapP,
pubmed-author:StepniewskaKasiaK,
pubmed-author:WARDA FAFJr,
pubmed-author:WhiteNicholas JNJ,
pubmed-author:ZwangJulienJ,
pubmed-author:van VugtMicheleM
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
e4551
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:19234601-Adolescent,
pubmed-meshheading:19234601-Antimalarials,
pubmed-meshheading:19234601-Artemisinins,
pubmed-meshheading:19234601-Clinical Trials as Topic,
pubmed-meshheading:19234601-Drug Resistance,
pubmed-meshheading:19234601-Female,
pubmed-meshheading:19234601-Humans,
pubmed-meshheading:19234601-Malaria, Falciparum,
pubmed-meshheading:19234601-Male,
pubmed-meshheading:19234601-Mefloquine,
pubmed-meshheading:19234601-Retrospective Studies,
pubmed-meshheading:19234601-Thailand,
pubmed-meshheading:19234601-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment.
|
